Cite
Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
MLA
Thomas M. Zizic, et al. “Risedronate Therapy Prevents Corticosteroid-Induced Bone Loss : A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.” Arthritis & Rheumatism, vol. 42, Nov. 1999, pp. 2309–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b0bde888a3556b6c60affa33ea6719bf&authtype=sso&custid=ns315887.
APA
Thomas M. Zizic, Chines Arkadi Aaron, Maria Greenwald, Douglas Wayne Axelrod, Barbara P. Lukert, Robert M. Levy, Stanley Wallach, Ronald Emkey, Eugene P. Boling, Michael Keller, Stanley Cohen, & Kathryn Lea Sewell. (1999). Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis & Rheumatism, 42, 2309–2318.
Chicago
Thomas M. Zizic, Chines Arkadi Aaron, Maria Greenwald, Douglas Wayne Axelrod, Barbara P. Lukert, Robert M. Levy, Stanley Wallach, et al. 1999. “Risedronate Therapy Prevents Corticosteroid-Induced Bone Loss : A Twelve-Month, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.” Arthritis & Rheumatism 42 (November): 2309–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b0bde888a3556b6c60affa33ea6719bf&authtype=sso&custid=ns315887.